![]() |
![]() |
Your cart is empty |
||
Showing 1 - 4 of 4 matches in All Departments
In spite of significant scientific progress in recent years, the
aetiopathogenesis of chronic inflammatory bowel diseases (IBD)
remains elusive. With a prevalence of 1: 700 to 1: 500 in central
Europe, both diseases are not rare. However, most physicians will
generally treat only a few patients with IBD in their clinical
practice. Because of this limited experience and the variety of
clinical IBD manifestations, IBD patients are frequently treated in
specialized tertiary care centres. Nevertheless, IBD patients will
also consult less specialized general practitioners, who will not
be able to focus extensively on the management of IBD patients due
to time constraints.
This book, the proceedings of a Falk Workshop on `Topical Steroids in Gastroenterology and Hepatology', held in Berlin, Germany, on 14 June 2003, critically discusses the current role of budesonide in gastroenterology, hepatology, surgery and oncology and focuses especially on potential new indications for the use of budesonide. A number of smaller clinical studies and anecdotal case reports with impressive clinical effects are reported in patients with gastrointestinal, hepatic, oncological and surgical problems. In addition, the use of budesonide for the treatment of distal ulcerative colitis and ileocolonic Crohn's disease is evaluated with respect to its role in an evidence-based management of IBD. Finally, as clinical experience with the use of budesonide is increasing, safety issues and the side-effect profile of budesonide is addressed.
Significant scientific progress has been made in recent years in the aetiopathogenesis of chronic inflammatory bowel diseases (IBD), that has changed or will change in the future the diagnostic and therapeutic approach in these diseases. The relevance of classical conventional IBD therapies has been critically re-evaluated under criteria of evidence-based medicine approaches. On the other hand, new therapeutic options have emerged. These include modern immunomodulators, biologics, probiotics, worm eggs and extracorporeal therapies. The clinical relevance of these new modalities is often difficult to assess for physicians who do not work frequently with IBD patients.
Fortschritte bei der Erforschung, Diagnostik und Therapie chronisch entzA1/4ndlicher Darmkrankheiten (CED) bedA1/4rfen in zunehmendem MaAe einer interdisziplinAren Kooperation von klinischen Gastroenterologen, Radiologen, Immunologen, Dermatologen und Rheumatologen. Der vorliegende Band fasst den aktuellen Stand zu extraintestinalen Komplikationen chronisch entzA1/4ndlicher Darmkrankheiten zusammen. Eingehend und kritisch diskutiert werden Manifestationen an der Haut, die wichtige Komplikation der Osteopenie, Gelenkmanifestationen und LeberverAnderungen. Es werden Spezialaspekte von CED in diesem Buch aktuell und in klinsch relevanter Bedeutung dargestellt. Wichtige therapeutische Probleme und LAsungsvorschlAge, auf die wir hAufig auch beim vermeintlich unkomplizierten M. Crohn stoAen, werden aufgezeigt.
|
![]() ![]() You may like...
Sizzlers - The Hate Crime That Tore Sea…
Nicole Engelbrecht
Paperback
The Unresolved National Question - Left…
Edward Webster, Karin Pampallis
Paperback
![]()
Lied Vir Sarah - Lesse Van My Ma
Jonathan Jansen, Naomi Jansen
Hardcover
![]()
Women In Solitary - Inside The Female…
Shanthini Naidoo
Paperback
![]()
Introducing Hibirism ... In The Meantime…
Donald Mokgale, Ernest Nkomotje
Paperback
|